Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-727.04%
operating margin TTM
-866.63%
revenue TTM
21.71 Million
revenue per share TTM
0.41$
valuation ratios | |
|---|---|
| pe ratio | -21.99 |
| peg ratio | 0.21 |
| price to book ratio | 2.63 |
| price to sales ratio | 122.55 |
| enterprise value multiple | -16.77 |
| price fair value | 2.63 |
profitability ratios | |
|---|---|
| gross profit margin | 84.78% |
| operating profit margin | -866.63% |
| pretax profit margin | -727.04% |
| net profit margin | -727.04% |
| return on assets | -13.12% |
| return on equity | -41.07% |
| return on capital employed | -16.59% |
liquidity ratios | |
|---|---|
| current ratio | 16.33 |
| quick ratio | 16.33 |
| cash ratio | 2.57 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 83.45 |
| days of payables outstanding | 603.88 |
| cash conversion cycle | -520.43 |
| receivables turnover | 4.37 |
| payables turnover | 0.60 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.02 |
| debt equity ratio | 0.02 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.02 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -6.70 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.53 |
| cash per share | 9.35 |
| operating cash flow per share | -1.36 |
| free cash flow operating cash flow ratio | 1.12 |
| cash flow coverage ratios | -6.70 |
| short term coverage ratios | -50.94 |
| capital expenditure coverage ratio | -8.12 |
Frequently Asked Questions
When was the last time Aktis Oncology, Inc. (NASDAQ:AKTS) reported earnings?
Aktis Oncology, Inc. (AKTS) published its most recent earnings results on 30-06-2026.
What is Aktis Oncology, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Aktis Oncology, Inc. (NASDAQ:AKTS)'s trailing twelve months ROE is -41.07%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Aktis Oncology, Inc. (AKTS) currently has a ROA of -13.12%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did AKTS's net profit margin stand at?
AKTS reported a profit margin of -727.04% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is AKTS's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 16.33 in the most recent quarter. The quick ratio stood at 16.33, with a Debt/Eq ratio of 0.02.